Animal models for researching approaches to therapy of Duchenne muscular dystrophy
Transgenic Research · 2021-12 · 30 (6) · 709-725
DOI: 10.1007/s11248-021-00278-3 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Transgenic Research, online erschienen am 18.08.2021. Verfasst von M I Zaynitdinova und 2 weiteren Autor:innen. Beteiligte Einrichtung: Research Centre for Medical Genetics, Moscow, Russia. milyazayn@gmail.com. Hauptthemen laut MEDLINE: Muscular Dystrophy, Duchenne. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 135 Literaturangaben.
Abstract (Originalsprache)
Duchenne muscular dystrophy (DMD) is a relatively widespread genetic disease which develops as a result of a mutation in the gene DMD encoding dystrophin. In this review, animal models of DMD are described. These models are used in preclinical studies to elucidate the pathogenesis of the disease or to develop effective treatments; each animal model has its own advantages and disadvantages. For instance, Caenorhabditis elegans, Drosophila melanogaster, and zebrafish (sapje) are suitable for large-scale chemical screening of large numbers of small molecules, but their disease phenotype differs from that of mammals. The use of larger animals is important for understanding of the potential efficacy of various treatments for DMD. While mdx mice have their advantages, they exhibit a milder disease phenotype compared to humans or dogs, making it difficult to evaluate the efficacy of new treatment for DMD. The disease in dogs and pigs is more severe and progresses faster than in mice, but it is more difficult to breed and obtain sufficient numbers of specimens in order to achieve statistically significant results. Moreover, working with large animals is also more labor-intensive. Therefore, when choosing the optimal animal model for research, it is worth considering all the goals and objectives.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Research Centre for Medical Genetics, Moscow, Russia. milyazayn@gmail.com.
- Research Centre for Medical Genetics, Moscow, Russia.
ORCID-Profile: M I Zaynitdinova, A V Lavrov, S A Smirnikhina
Zitieren
APA
Zaynitdinova, M. I., Lavrov, A. V., & Smirnikhina, S. A. (2021). Animal models for researching approaches to therapy of Duchenne muscular dystrophy. Transgenic Research, 30(6), 709-725. https://doi.org/10.1007/s11248-021-00278-3
Vancouver
Zaynitdinova MI, Lavrov AV, Smirnikhina SA. Animal models for researching approaches to therapy of Duchenne muscular dystrophy. Transgenic Research. 2021;30(6):709-725. doi:10.1007/s11248-021-00278-3
BibTeX
@article{Zaynitdinova2021,
author = {Zaynitdinova, M I and Lavrov, A V and Smirnikhina, S A},
title = {Animal models for researching approaches to therapy of Duchenne muscular dystrophy},
journal = {Transgenic Research},
year = {2021},
volume = {30},
number = {6},
pages = {709--725},
doi = {10.1007/s11248-021-00278-3}
}
EUVIMED